Novo Nordisk's new CEO is set to face intense investor scrutiny this week as the Wegovy-maker shakes up its board and pursues ...

Novo Holdings, which controls obesity drugmaker Novo Nordisk, is sharpening its focus on India, targeting single-specialty ...

Novo Holdings, which controls obesity drugmaker Novo Nordisk, is sharpening its focus on India, targeting single-specialty ...

Novo, whose largest Asia investment to-date has been a minority stake in India's Manipal Hospitals in 2024, is focused on ...

Analysts expect Novo Nordisk’s Q3 revenue to fall 2% to $11.87 billion and earnings per share to drop as competition from Eli ...

Scientists at UC San Diego’s Scripps Institution of Oceanography have described a new way to produce large amounts of xanthommatin, a natural pigment, in a bacterium for the first time. Xanthommatin ...

Novo Nordisk's new CEO, Mike Doustdar, is under significant pressure as the company contends with declining stock prices, ...

Get key Q3 2025 earnings insights for Hims & Hers Health (HIMS): revenue growth, new partnerships, and global expansion plans.

SHELTON, CONNECTICUT / ACCESS Newswire / November 3, 2025 / NanoViricides, Inc. (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot ...

The start of what’s known as the best month of the year for stocks saw tech rallying as Amazon.com Inc.’s $38 billion deal with OpenAI added fuel to the artificial-intelligence trade. Bond yields rose ...

From discontinued insulin pens to overpriced TB drugs, meet the young South African holding drug makers to account on behalf of patients.